168 related articles for article (PubMed ID: 36541716)
1. Multifunctional Protein Hybrid Nanoplatform for Synergetic Photodynamic-Chemotherapy of Malignant Carcinoma by Homologous Targeting Combined with Oxygen Transport.
Wu SY; Ye YX; Zhang Q; Kang QJ; Xu ZM; Ren SZ; Lin F; Duan YT; Xu HJ; Hu ZY; Yang SS; Zhu HL; Zou MJ; Wang ZC
Adv Sci (Weinh); 2023 Feb; 10(5):e2203742. PubMed ID: 36541716
[TBL] [Abstract][Full Text] [Related]
2. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
3. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
4. Oxygen Self-Sufficient Core-Shell Metal-Organic Framework-Based Smart Nanoplatform for Enhanced Synergistic Chemotherapy and Photodynamic Therapy.
Ren SZ; Wang B; Zhu XH; Zhu D; Liu M; Li SK; Yang YS; Wang ZC; Zhu HL
ACS Appl Mater Interfaces; 2020 Jun; 12(22):24662-24674. PubMed ID: 32394704
[TBL] [Abstract][Full Text] [Related]
5. Oxygen-Self-Supplying and HIF-1α-Inhibiting Core-Shell Nanosystem for Hypoxia-Resistant Photodynamic Therapy.
Liu P; Xie X; Shi X; Peng Y; Ding J; Zhou W
ACS Appl Mater Interfaces; 2019 Dec; 11(51):48261-48270. PubMed ID: 31763809
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose.
Luo Z; Tian H; Liu L; Chen Z; Liang R; Chen Z; Wu Z; Ma A; Zheng M; Cai L
Theranostics; 2018; 8(13):3584-3596. PubMed ID: 30026868
[TBL] [Abstract][Full Text] [Related]
7. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271
[TBL] [Abstract][Full Text] [Related]
8. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
[TBL] [Abstract][Full Text] [Related]
9. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
[TBL] [Abstract][Full Text] [Related]
10. Dual-action nanoplatform with a synergetic strategy to promote oxygen accumulation for enhanced photodynamic therapy against hypoxic tumors.
Ren C; Xu X; Yan D; Gu M; Zhang J; Zhang H; Han C; Kong L
Acta Biomater; 2022 Jul; 146():465-477. PubMed ID: 35526738
[TBL] [Abstract][Full Text] [Related]
11. Enhancing selective photosensitizer accumulation and oxygen supply for high-efficacy photodynamic therapy toward glioma by 5-aminolevulinic acid loaded nanoplatform.
Wang X; Tian Y; Liao X; Tang Y; Ni Q; Sun J; Zhao Y; Zhang J; Teng Z; Lu G
J Colloid Interface Sci; 2020 Apr; 565():483-493. PubMed ID: 31982715
[TBL] [Abstract][Full Text] [Related]
12. Tumor homing-penetrating and nanoenzyme-augmented 2D phototheranostics against hypoxic solid tumors.
Wu C; Zhang Y; Wei X; Li N; Huang H; Xie Z; Zhang H; Yang G; Li M; Li T; Yang H; Li S; Qin X; Liu Y
Acta Biomater; 2022 Sep; 150():391-401. PubMed ID: 35917909
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted nanoplatforms for enhanced photodynamic therapy against hypoxia tumor.
Wen J; Luo Y; Gao H; Zhang L; Wang X; Huang J; Shang T; Zhou D; Wang D; Wang Z; Li P; Wang Z
J Nanobiotechnology; 2021 Dec; 19(1):440. PubMed ID: 34930284
[TBL] [Abstract][Full Text] [Related]
14. Hybrid biointerface engineering nanoplatform for dual-targeted tumor hypoxia relief and enhanced photodynamic therapy.
Zhen X; Jia L; Tang Q; Zhao Y; Li P; Li J; Xie X; Wang S
J Colloid Interface Sci; 2023 Oct; 647():211-223. PubMed ID: 37247484
[TBL] [Abstract][Full Text] [Related]
15. Fucoidan-based, tumor-activated nanoplatform for overcoming hypoxia and enhancing photodynamic therapy and antitumor immunity.
Chung CH; Lu KY; Lee WC; Hsu WJ; Lee WF; Dai JZ; Shueng PW; Lin CW; Mi FL
Biomaterials; 2020 Oct; 257():120227. PubMed ID: 32738653
[TBL] [Abstract][Full Text] [Related]
16. Hybrid Nanomedicine Fabricated from Photosensitizer-Terminated Metal-Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia-Activated Cascade Chemotherapy.
He Z; Dai Y; Li X; Guo D; Liu Y; Huang X; Jiang J; Wang S; Zhu G; Zhang F; Lin L; Zhu JJ; Yu G; Chen X
Small; 2019 Jan; 15(4):e1804131. PubMed ID: 30565431
[TBL] [Abstract][Full Text] [Related]
17. Cancer-Responsive Multifunctional Nanoplatform Based on Peptide Self-Assembly for Highly Efficient Combined Cancer Therapy by Alleviating Hypoxia and Improving the Immunosuppressive Microenvironment.
Wu J; Liu Y; Cao M; Zheng N; Ma H; Ye X; Yang N; Liu Z; Liao W; Sun L
ACS Appl Mater Interfaces; 2023 Feb; 15(4):5667-5678. PubMed ID: 36651290
[TBL] [Abstract][Full Text] [Related]
18. 3-Bromopyruvate-Conjugated Nanoplatform-Induced Pro-Death Autophagy for Enhanced Photodynamic Therapy against Hypoxic Tumor.
Deng Y; Song P; Chen X; Huang Y; Hong L; Jin Q; Ji J
ACS Nano; 2020 Aug; 14(8):9711-9727. PubMed ID: 32806075
[TBL] [Abstract][Full Text] [Related]
19. Gold Cube-in-Cube Based Oxygen Nanogenerator: A Theranostic Nanoplatform for Modulating Tumor Microenvironment for Precise Chemo-Phototherapy and Multimodal Imaging.
Zhang X; Xi Z; Machuki JO; Luo J; Yang D; Li J; Cai W; Yang Y; Zhang L; Tian J; Guo K; Yu Y; Gao F
ACS Nano; 2019 May; 13(5):5306-5325. PubMed ID: 31018094
[TBL] [Abstract][Full Text] [Related]
20. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
